Journal Mobile Options
Table of Contents
Vol. 24, No. 4, 2008
Issue release date: January 2009
Fetal Diagn Ther 2008;24:400–404

Utility of Fetal Muscle Biopsy for Diagnosis of Nemaline Myopathy

Kasperski S.B. · Brennan A.M. · Corteville J.E. · Finkel R.S. · Golden J. · Johnson M.P. · Wilson R.D.
aThe Center for Fetal Diagnosis and Treatment at the Children’s Hospital of Philadelphia, Philadelphia, Pa., Departments of bObstetrics, cNeurology and dPathology, University of Pennsylvania School of Medicine, Philadelphia, Pa., and eMetro Health Center, Cleveland, Ohio, USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objectives: To report and discuss prenatal diagnosis of nemaline myopathy (NM) using fetal muscle biopsy. Methods: A consanguineous couple, with a history of a child with a clinical diagnosis of NM but no molecular genetic confirmation, was referred for prenatal diagnosis in two subsequent pregnancies. Fetal muscle biopsy with ultrasound guidance was undertaken at 22 and 21 weeks, respectively. Results: Immunohistochemical and ultrastructural analysis of the fetal muscle specimen from the first ‘at-risk’ pregnancy was consistent with a diagnosis of NM and that pregnancy was terminated. Analysis of the fetal muscle specimen from the subsequent pregnancy revealed no pathologic abnormality. The pregnancy continued, and the child is unaffected. Conclusion: This represents the first reported prenatal diagnosis of NM by fetal muscle biopsy. Pathologic changes characteristic of NM can be identified in mid-second trimester fetal muscle.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Agrawal PB, Strickland CD, Midgett C, Morales A, Newburger DE, Poulos MA, Tomczak KK, Ryan MM, Iannaccone ST, Crawford TO, Laing NG, Beggs AH: Heterogeneity of nemaline myopathy cases with skeletal muscle α-actin gene mutations. Ann Neurol 2004;56:86–96
  2. Anderson SL, Ekstein J, Donnelly MC, Keefe EM, Toto NR, LeVoci LA, Rubin BY: Nemaline myopathy in the Ashkenazi Jewish population is caused by a deletion in the nebulin gene. Hum Genet 2004;115:186–190.

    External Resources

  3. Arts WF, Bethlem J, Dingemans KP, Eriksson AW: Investigations on the inheritance of nemaline myopathy Arch Neurol 1978;35:72–77.
  4. Chahin N, Selcen D, Engel AG: Sporadic late onset nemaline myopathy. Neurology 2005;65:1158–1164.
  5. Donner K, Ollikainen M, Ridanpaa M, Christen HJ, Goebel JJ, de Visser M, Pelin K, Wallgren-Pettersson C: Mutations in the β-tropomyosin (TPM2) gene – a rare cause of nemaline myopathy. Neuromuscul Disord 2002;12:151–158.
  6. Durling HJ, Reilich P, Muller-Hocker J, Mendel B, Pongratz D, Wallgren-Pettersson C, Gunning P, Lochmuller H, Laing NG: De novo missense mutation in a constitutively expressed exon of the slow α-tropomsyosin gene TPM3 associated with an atypical, sporadic case of nemaline myopathy. Neuromuscul Disord 2002;12:947–951.
  7. Evans MI, Farrell SA, Greb A, Ray P, Johnson MJ, Hoffman EP: In utero fetal muscle biopsy for the diagnosis of Duchenne muscular dystrophy in a female fetus ‘suddenly at risk’. Am J Med Genet 1993;46:309–312.
  8. Evans MI, Greb A, Kunkel LM, Sacks AJ, Johnson MP, Boehm C, Kazazian HH, Hoffman EP: In utero fetal muscle biopsy for the diagnosis of Duchenne muscular dystrophy. Am J Obstet Gynecol 1991;165:728–732.
  9. Evans MI, Hoffman EP, Cadrin C, Johnson MP, Quintero RA, Golbus MS: Fetal muscle biopsy: collaborative experience with varied indications. Obstet Gynecol 1994;84:913–917.
  10. Gommans IM, Davis M, Saar K, Lammens M, Mastaglia F, Lamont P, van Duijnhoven G, ter Laak HJ, Reis A, Vogels OJ, Laing N, van Engelen BG, Kremer H: A locus on chromosome 15q for a dominantly inherited nemaline myopathy with core-like lesions. Brain 2003;126:1545–1551.
  11. Gyure KA, Prayson RA, Estes ML: Adult-onset nemaline myopathy: a case report and review of the literature. Arch Pathol Lab Med 1997;121:1210–1213.
  12. Ilkovski B, Cooper ST, Novak K, Ryan MM, Yang N, Schnell C, Durling HJ, Roddick LG, Wilkinson I, Kornberg AJ, Collins KJ, Wallace G, Gunning P, Hardeman EC, Laing NG, North KN: Nemaline myopathy caused by mutations in the muscle α-skeletal-actin gene. Am J Hum Genet 2001;68:1333–1343.
  13. Jin JP, Brotto MA, Hossain MM, Juang QQ, Brotto LS, Nosek TM, Morton DH, Crawford TO: Truncation by Glu180 nonsense mutation results in complete loss of slow skeletal muscle troponin T in a lethal nemaline myopathy. J Biol Chem 2003;278:26159–26165.
  14. Johnston JJ, Kelley RI, Crawford TO, Morton DH, Agarwala R, Koch T, Schaffer AA, Francomano CA, Biesecker LG: A novel nemaline myopathy in the Amish caused by a mutation in troponin T1. Am J Hum Genet 2000;67:814–821.
  15. Laing NG, Majda BT, Akkari PA, Layton MG, Mulley JC, Phillips H, Haan EA, White SJ, Beggs AH, Kunkel LM, et al: Assignment of a gene (NEMI) for autosomal dominant nemaline myopathy to chromosome I. Am J Hum Genet 1992;50:576–583.
  16. Lammens M, Moerman P, Fryns JP, Lemmens F, van de Kamp GM, Goemans N, Dom R: Fetal akinesia sequence caused by nemaline myopathy. Neuropediatrics 1997;28:116–119.
  17. Lomen-Hoerth C, Simmons ML, Dearmond SJ, Layzer RB: Adult-onset nemaline myopathy: another cause of dropped head. Muscle Nerve 1999;22:1146–1150.
  18. North KN, Laing NG, Wallgreen-Pattersson C: Nemaline myopathy: current concepts. The ENMC International Consortium and Nemaline Myopathy. J Med Gen 1997;34:705–713.
  19. North K, Ryan M: Nemaline myopathy. 2006. Available online at (accessed October 2007).
  20. Nowak KJ, Wattanasirichaigoon D, Goebel HN, Wilce M, Pelin K, Donner K, Jacob RL, Hubner C, Oexle K, Anderson JR, Verity CM, North KN, Iannaccone ST, Muller CR, Nurnberg P, Muntoni F, Sewry C, Hughes I, Sutphen R, Lacson AG, Swoboda KJ, Vigneron J, Wallgren-Pettersson C, Beggs AH, Laing NG: Mutations in the skeletal muscle α-actin gene in patients with actin myopathy and nemaline myopathy. Nat Genet 1999;23:208–212.
  21. Pauw-Gommans IM, Gerrits KH, de Haan A, van Engelen BG: Muscle slowness in a family with nemaline myopathy. Neuromuscul Disord 2006;16:477–480.
  22. Pelin K, Hilpela P, Donner K, Sewry C, Akkari PA, Wilton SD, Wattanasirichaigoon D, Bang ML, Centner T, Hanefeld F, Odent S, Fardeau M, Urtizberea JA, Muntoni F, Dubowitz V, Beggs AH, Laing NG, Labeit S, de la Chapelle A, Wallgren-Pettersson C: Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proc Natl Acad Sci USA 1999;96:2305–2310.
  23. Ryan MM, Ilkovski B, Strickland CD, Schnell C, Sanoudou D, Midgett C, Houston R, Muirhead D, Dennett X, Shield LK, De Girolami U, Iannaccone ST, Laing NG, North KN, Beggs AH: Clinical course correlates poorly with muscle pathology in nemaline myopathy. Neurology 2003;60:665–673.
  24. Ryan MM, Schnell C, Strickland CD, Shield LK, Morgan G, Iannaccone ST, Laing NG, Beggs AH, North KN: Nemaline myopathy: a clinical study of 143 cases. Ann Neurol 2001;50:312–320.
  25. Sanoudou D, Beggs AH: Clinical and genetic heterogeneity in nemaline myopathy – a disease of skeletal muscle thin filaments. Trends Mol Med 2001;7:362–368.
  26. Strickland CD, et al: Clinical and pathological variability of congenital myopathies caused by mutations in skeletal muscle-actin. Am J Hum Genet 2000;67:A378.
  27. Tan P, Briner J, Boltshauser E, Davis MR, Wilton SD, North K, Wallgren-Pettersson C, Laing NG: Homozygosity for a nonsense mutation in the α-tropomyosin slow gene TPM3 in a patient with severe infantile nemaline myopathy. Neuromuscul Disord 1999;9:573–579.
  28. Wallgren-Pettersson C: Congenital Nemaline Myopathy: A Longitudinal Study; Thesis/Dissertation, Helsinki 1990.
  29. Wallgren-Pettersson C, Beggs AH, Laing NG: 51st ENMC International Workshop: Nemaline Myopathy, June 13–15, 1997, Naarden, The Netherlands. Neuromuscul Disord 1998;8:53–56.
  30. Wallgren-Pettersson C, Laing NG: Report of the 70th ENMC International Workshop: Nemaline Myopathy, June 11–13 1999, Naarden, The Netherlands. Neuromuscul Disord 2000;10:299–306.
  31. Wallgren-Pettersson C, Laing NG: 109th ENMC International Workshop: 5th Workshop on Nemaline Myopathy, October 11–13 2002, Naarden, The Netherlands. Neuromuscul Disord 2003;13:501–507.
  32. Wallgren-Pettersson C, Pelin K, Hilpela P, Donner K, Porfirio B, Graziano C, Swoboda KJ, Fardeau M, Urtizberea JA, Muntoni F, Sewry C, Dubowitz V, Iannaccone S, Minetti C, Pedemonte M, Seri M, Cusano R, Lammens M, Castagna-Sloane A, Beggs AH, Laing NG, de la Chapelle A: Clinical and genetic heterogeneity in autosomal recessive nemaline myopathy. Neuromuscul Disord 1999;9:564–572.
  33. Wallgren-Pettersson C, Rapola J, Donner M: Pathology of congenital nemaline myopathy. A follow-up study. J Neurol Sci 1988;83:243–257.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50